Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021)
Elicio Therapeutics (ELTX) reported Gross Profit of $24.7 million for Q4 2021, up 1149.36% on a YoY basis from $2.0 million in Q4 2020, and up 1591.92% quarter-over-quarter from $1.5 million in Q3 2021.
Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021) Analysis & Trends
Elicio Therapeutics has reported Gross Profit for 2 years, with the latest figure at $24.7 million in Q4 2021.
- For the quarter ending Q4 2021, Gross Profit rose 1149.36% year-over-year to $24.7 million; the trailing twelve-month figure through Dec 2021 stood at $27.1 million (up 1553.97% YoY), and the FY2022 full-year result was $2.3 million, down 91.5% from the prior year.
- Gross Profit for Q4 2021 stood at $24.7 million, up from $1.5 million in the prior quarter.
- The five-year high for Gross Profit was $24.7 million in Q4 2021, with the low at -$2.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 24.70 Mn |
| Dec 31, 2021 | 24.70 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 540,000.00 |
| Jun 30, 2021 | 540,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Dec 31, 2020 | -2.35 Mn |
| Dec 31, 2020 | -2.35 Mn |
| Sep 30, 2020 | 479,000.00 |
| Sep 30, 2020 | 479,000.00 |
| Jun 30, 2020 | 396,000.00 |
| Jun 30, 2020 | 396,000.00 |
| Mar 31, 2020 | -383,000.00 |
| Mar 31, 2020 | -383,000.00 |